Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Journal of Wildlife Diseases
|
October 17, 2023
RABIES IN RODENTS AND LAGOMORPHS IN THE USA, 2011-20
Dariusz A Hareza, Ricky Langley, Xiaoyue Ma, et al.
Pharmacological Reports : PR
|
June 19, 2025
Empiric and targeted antibiotic therapy for bloodstream infections in internal medicine patients in Poland: a three-year analysis in a single centre using the AWaRe classification
Piotr Piekiełko, Dariusz A Hareza, Ewa Stawowczyk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 16, 2023
Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum β-Lactamase-Producing Enterobacterales Bloodstream Infections?
Dariusz A Hareza, Sara E Cosgrove, Patricia J Simner, et al.
Antimicrobial Agents and Chemotherapy
|
September 4, 2024
Clinical outcomes and emergence of resistance of <i>Pseudomonas aeruginosa</i> infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam
Dariusz A Hareza, Sara E Cosgrove, Robert A Bonomo, et al.
Infection Control and Hospital Epidemiology
|
April 19, 2021
Clinical characteristics of hospitalized patients with false-negative severe acute respiratory coronavirus virus 2 (SARS-CoV-2) test results
Erica L MacKenzie, Dariusz A Hareza, Maggie W Collison, et al.
Antimicrobial Agents and Chemotherapy
|
January 27, 2025
Molecular epidemiology of β-lactamases in ceftriaxone-resistant Enterobacterales bloodstream infections in the mid-Atlantic United States
Dariusz A Hareza, Yehudit Bergman, Emily Jacobs, et al.
Polish Archives of Internal Medicine
|
April 24, 2024
Molecular epidemiology and clinical significance of carbapenemase genes in carbapenem-resistant Acinetobacter baumannii isolates in southern Poland
Piotr A Serwacki, Dariusz A Hareza, Anna Kujawska, et al.
Antimicrobial Agents and Chemotherapy
|
March 23, 2026
Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infections
Sara M Karaba, Dariusz A Hareza, Jose M Munita, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Journal of Wildlife Diseases
|
October 17, 2023
RABIES IN RODENTS AND LAGOMORPHS IN THE USA, 2011-20
Dariusz A Hareza, Ricky Langley, Xiaoyue Ma, et al.
Pharmacological Reports : PR
|
June 19, 2025
Empiric and targeted antibiotic therapy for bloodstream infections in internal medicine patients in Poland: a three-year analysis in a single centre using the AWaRe classification
Piotr Piekiełko, Dariusz A Hareza, Ewa Stawowczyk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 16, 2023
Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum β-Lactamase-Producing Enterobacterales Bloodstream Infections?
Dariusz A Hareza, Sara E Cosgrove, Patricia J Simner, et al.
Antimicrobial Agents and Chemotherapy
|
September 4, 2024
Clinical outcomes and emergence of resistance of <i>Pseudomonas aeruginosa</i> infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam
Dariusz A Hareza, Sara E Cosgrove, Robert A Bonomo, et al.
Infection Control and Hospital Epidemiology
|
April 19, 2021
Clinical characteristics of hospitalized patients with false-negative severe acute respiratory coronavirus virus 2 (SARS-CoV-2) test results
Erica L MacKenzie, Dariusz A Hareza, Maggie W Collison, et al.
Antimicrobial Agents and Chemotherapy
|
January 27, 2025
Molecular epidemiology of β-lactamases in ceftriaxone-resistant Enterobacterales bloodstream infections in the mid-Atlantic United States
Dariusz A Hareza, Yehudit Bergman, Emily Jacobs, et al.
Polish Archives of Internal Medicine
|
April 24, 2024
Molecular epidemiology and clinical significance of carbapenemase genes in carbapenem-resistant Acinetobacter baumannii isolates in southern Poland
Piotr A Serwacki, Dariusz A Hareza, Anna Kujawska, et al.
Antimicrobial Agents and Chemotherapy
|
March 23, 2026
Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infections
Sara M Karaba, Dariusz A Hareza, Jose M Munita, et al.
Page
of 1